Valentina Tarasova, MD

Cancer Focus:
Adrenal Cancer, Adrenal Nodule/Mass, Neuroendocrine Tumor, Pituitary Macroadenoma, Pituitary Microadenoma, Pituitary Neoplasm, Thyroid Cancer, Thyroid Nodule/Mass

 Dr. Tarasova is an Endocrinologist at Moffitt Cancer Center, specializing in endocrine oncology. She completed her Internal Medicine residency at Yale New Haven Hospital, Saint Raphael Campus, Yale School of Medicine in New Haven, CT, followed by a fellowship in Endocrinology, Diabetes, and Metabolism at Creighton University in Omaha, NE.

 

Dr. Tarasova went on to complete an Interdisciplinary Medical Thyroid Cancer Fellowship at Memorial Sloan Kettering Cancer Center in New York and the Global Clinical Scholars Research Training (GCSRT) Program at Harvard Medical School in Boston.

 

Her clinical interests focus on thyroid neoplasms, particularly the diagnosis, monitoring, and treatment of thyroid carcinoma—from low-risk to advanced, progressive forms. She is a key member of the multidisciplinary team managing patients with thyroid nodules and thyroid cancer. Her research interests include the role of molecular markers in diagnosing and determining the prognosis of thyroid neoplasms, risk stratification in thyroid cancer, and the development of tools to estimate prognosis and guide clinical management.

 

Dr. Tarasova serves as the Program Director for the Endocrine Oncology Fellowship and as the Moffitt site director for the University of South Florida’s Endocrinology, Diabetes, and Metabolism Fellowship. She has been recognized as one of Tampa Bay’s Top Endocrinologists since 2022.

 

Education & Training

Board Certification:

• Internal Medicine - Endocrinology, Diabetes & Metabolism

Fellowship:

• Creighton University - Endocrinology, Diabetes, Metabolism
• Memorial Sloan Kettering Cancer Center - Thyroid Cancer

Residency:

• Yale New Haven Hospital, Yale School of Medicine - Internal Medicine

Medical School:

• Kubansky State Medical University - MD

• Tarasova VD, Chung CH, Agosto Salgado S. Durable Response to Redifferentiation in a Patient With Metastatic NCOA4::RET Fusion-driven Papillary Thyroid Cancer. JCEM Case Rep. 2025 Jun.3(6):luaf054. Pubmedid: 40330117. Pmcid: PMC12050687.
• Tarasova VD, Samuel K, McMullen C, Kushchayev S, Hernandez Prera JC, Veloski C. Thyroid Paraganglioma: A Rare Manifestation of Paraganglioma Syndrome Associated With Pathogenic Variant in SDHD. JCEM Case Rep. 2024 Sep.2(9):luae135. Pubmedid: 39156002. Pmcid: PMC11327117.
• Tarasova VD, Tsai J, Masannat J, Hernandez-Prera J, Hallanger-Johnson JE, Veloski C, Agosto Salgado S, McIver B, Drusbosky L, Chung CH. Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing. Thyroid. 2024 Feb.34(2):197-205. Pubmedid: 37962267.
• Tasoulas J, Srivastava S, Xu X, Tarasova V, Maniakas A, Karreth FA, Amelio AL. Genetically engineered mouse models of head and neck cancers. Oncogene. 2023 Aug.42(35):2593-2609. Pubmedid: 37474617. Pmcid: PMC10457205.
• Hernandez-Prera J, Valderrabano P, Creed J, de la Iglesia JV, Slebos R, Centeno BA, Tarasova V, Hallanger-Johnson J, Veloski C, Otto KJ, Wenig BM, Yoder S, Lam C, Park DS, Anderson AR, Raghunand N, Berglund A, Caudell J, Gerke TA, Chung CH. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS Mutations. Thyroid. 2021 Jan.31(1):36-49. Pubmedid: 32689909. Pmcid: PMC7864115.
• Bayona A, Benavent P, Muriel A, Abuchaibe C, Sharpe SC, Tarasova V, McIver B, Valderrabano P. Outcomes of repeat fineneedle aspiration biopsy for AUS/FLUS thyroid nodules. Eur J Endocrinol. 2021 Aug.185(4):497-506. Pubmedid: 34313606.
• Valderrabano P, Khazai L, Thompson ZJ, Sharpe SC, Tarasova VD, Otto KJ, Hallanger-Johnson JE, Wadsworth JT, Wenig BM, Chung CH, Centeno BA, McIver B. Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis. Thyroid. 2018 Feb.28(2):210-219. Pubmedid: 29160163. Pmcid: PMC7869885.
• Tarasova VD, Tuttle RM. Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma. Clin Oncol (R Coll Radiol). 2017 May.29(5):290-297. Pubmedid: 28087101.
• Tarasova VD, Tuttle RM. A Risk-adapted Approach to Follow-up in Differentiated Thyroid Cancer. Rambam Maimonides Med J. 2016 Jan.7(1). Pubmedid: 26886955. Pmcid: PMC4737510.
• Shah KK, Tarasova V, Davidian M, Anderson RJ. Painful acute radiation thyroiditis induced by 131I treatment of Graves' disease. BMJ Case Rep. 2015 Jan.2015. Pubmedid: 25576511. Pmcid: PMC4289741.
• Tarasova VD, Caballero JA, Turner P, Inzucchi SE. Speaking to Patients About Diabetes Risk: Is Terminology Important?. Clin Diabetes. 2014 Apr.32(2):90-95. Pubmedid: 26130869. Pmcid: PMC4485246.
• Tarasova VD, Zena M, Rendell M. Artifactual hypoglycemia: an old term for a new classification. Diabetes Care. 2014.37(5):e85-e86. Pubmedid: 24757247.
• Tarasova VD, Trepp-Carrasco AG, Thompson R, Recker RR, Chong WH, Collins MT, Armas LA. Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy. J Clin Endocrinol Metab. 2013 Nov.98(11):4267-4272. Pubmedid: 24014621. Pmcid: PMC5399525.

Voted top doctor in Endocrinology in Tampa Magazine’s Top Doctors 2025.

Voted top doctor in Endocrinology in Tampa Magazine's Top Doctors 2024.